Upstream Bio Competitors and Similar CompaniesClear all
Upstream Bio's competitors and similar companies include AbClon and Creative Bio-Peptides.
 Upstream Bio Upstream Bio is a clinical-stage biotechnology company that develops treatments for inflammatory diseases. |  Creative Bio-Peptides Creative Bio-Peptides (CBP) is a company that develops disease-modifying oral chemokine antagonist peptides that repair and regenerate damaged neurons. | ||
Founding Date | Founding Date 2021 | Founding Date 2010 | Founding Date 2017 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Waltham, US HQ | Locations KR HQ | Locations Rockville, US HQ |
Employees | Employees 38 | Employees N/A | Employees 4 |
Financial | |||
Revenue (est.) | Revenue (est.) $2.9m (FY, 2025) | Revenue (est.) ₩2.3b (FY, 2024) | Revenue (est.) N/A |
Cost of goods | Cost of goods $23m (FY, 2025) | Cost of goods (₩74.1m) (FY, 2024) | Cost of goods N/A |
Gross profit | Gross profit ($20.2m) (FY, 2025) | Gross profit ₩2.4b (FY, 2024) | Gross profit N/A |
Net income | Net income ($143.4m) (FY, 2025) | Net income (₩16.3b) (FY, 2024) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
AbClon
HQ
KR
AbClon (앱클론(주)) is a developer, manufacturer, and distributor of antibody drugs.
View companyCreative Bio-Peptides
HQ
Rockville, US
Employees
4
Creative Bio-Peptides (CBP) is a company that develops disease-modifying oral chemokine antagonist peptides that repair and regenerate damaged neurons.
View company